AAAAAA

   
Results: 1-17 |
Results: 17
Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation
Authors: Kovac, C Chie, L Morin, J Friedman, FK Robinson, R Chung, DL Kanovsky, M Flom, J Brandt-Rauf, PW Yamaizumi, Z Michl, J Pincus, MR
Citation: C. Kovac et al., Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation, CANC CHEMOT, 48(1), 2001, pp. 9-14
Common conformational effects of p53 mutations
Authors: Chen, JM Rosal, R Smith, S Pincus, MR Brandt-Rauf, PW
Citation: Jm. Chen et al., Common conformational effects of p53 mutations, J PROTEIN C, 20(2), 2001, pp. 101-105
Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress
Authors: Buschmann, T Potapova, O Bar-Shira, A Ivanov, VN Fuchs, SY Henderson, S Fried, VA Minamoto, T Alarcon-Vargas, D Pincus, MR Gaarde, WA Holbrook, NJ Shiloh, Y Ronai, Z
Citation: T. Buschmann et al., Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress, MOL CELL B, 21(8), 2001, pp. 2743-2754
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells
Authors: Kanovsky, M Raffo, A Drew, L Rosal, R Do, T Friedman, FK Rubinstein, P Visser, J Robinson, R Brandt-Rauf, PW Michl, J Fine, RL Pincus, MR
Citation: M. Kanovsky et al., Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells, P NAS US, 98(22), 2001, pp. 12438-12443
Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes
Authors: Ranginwale, M Smith, S Flom, J Chie, L Kanovsky, M Chung, D Friedman, FK Robinson, RC Brandt-Rauf, PW Yamaizumi, Z Michl, J Pincus, MR
Citation: M. Ranginwale et al., Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes, EXP CELL RE, 269(1), 2001, pp. 162-169
Molecular modeling of mammalian cytochrome P450s
Authors: Dai, R Pincus, MR Friedman, FK
Citation: R. Dai et al., Molecular modeling of mammalian cytochrome P450s, CELL MOL L, 57(3), 2000, pp. 487-499
ras-p21-induced cell transformation: Unique signal transduction pathways and implications for the design of new chemotherapeutic agents
Authors: Pincus, MR Brandt-Rauf, PW Michl, J Carty, RP Friedman, FK
Citation: Mr. Pincus et al., ras-p21-induced cell transformation: Unique signal transduction pathways and implications for the design of new chemotherapeutic agents, CANCER INV, 18(1), 2000, pp. 39-50
Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway
Authors: Chie, L Amar, S Kung, HF Lin, MCM Chen, H Chung, DL Adler, V Ronai, Z Friedman, FK Robinson, RC Kovac, C Brandt-Rauf, PW Yamaizumi, Z Michl, J Pincus, MR
Citation: L. Chie et al., Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway, CANC CHEMOT, 45(6), 2000, pp. 441-449
Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signaling
Authors: Chen, JM Rijhwani, K Friedman, FK Hyde, MJ Pincus, MR
Citation: Jm. Chen et al., Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signaling, J PROTEIN C, 19(7), 2000, pp. 545-551
Glutathione-S-transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase
Authors: Villafania, A Anwar, K Amar, S Chie, L Way, D Chung, DL Adler, V Ronai, Z Brandt-Rauf, PW Yamaizumii, Z Kung, HF Pincus, MR
Citation: A. Villafania et al., Glutathione-S-transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase, ANN CLIN L, 30(1), 2000, pp. 57-64
Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamics
Authors: Monaco, R Friedman, FK Hyde, MJ Chen, JM Manolatus, S Adler, V Ronai, Z Koslosky, W Pincus, MR
Citation: R. Monaco et al., Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamics, J PROTEIN C, 18(8), 1999, pp. 859-866
Molecular dynamics analysis of the structures of ras-guanine nucleotide exchange protein (SOS) bound to wild-type and oncogenic ras-p21. Identification of effector domains of SOS
Authors: Chen, JM Friedman, FK Hyde, MJ Monaco, R Pincus, MR
Citation: Jm. Chen et al., Molecular dynamics analysis of the structures of ras-guanine nucleotide exchange protein (SOS) bound to wild-type and oncogenic ras-p21. Identification of effector domains of SOS, J PROTEIN C, 18(8), 1999, pp. 867-874
Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations, selective inhibition of oncogenic ras-p21
Authors: Chie, L Chen, JM Friedman, FK Chung, DL Amar, S Michl, J Yamaizumi, Z Brandt-Rauf, PW Pincus, MR
Citation: L. Chie et al., Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations, selective inhibition of oncogenic ras-p21, J PROTEIN C, 18(8), 1999, pp. 875-879
Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain
Authors: Chie, L Chen, JM Friedman, FK Chung, DL Amar, S Michl, J Yamaizumi, Z Brandt-Rauf, PW Pincus, MR
Citation: L. Chie et al., Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain, J PROTEIN C, 18(8), 1999, pp. 881-884
Common conformational effects in the p53 protein of vinyl chloride-inducedmutations
Authors: Chen, JM Smith, SJ Marion, MJ Pincus, MR Brandt-Rauf, PW
Citation: Jm. Chen et al., Common conformational effects in the p53 protein of vinyl chloride-inducedmutations, J PROTEIN C, 18(4), 1999, pp. 467-472
Regulation of JNK signaling by GSTp
Authors: Adler, V Yin, ZM Fuchs, SY Benezra, M Rosario, L Tew, KD Pincus, MR Sardana, M Henderson, CJ Wolf, CR Davis, RJ Ronai, Z
Citation: V. Adler et al., Regulation of JNK signaling by GSTp, EMBO J, 18(5), 1999, pp. 1321-1334
Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells
Authors: Kim, AL Raffo, AJ Brandt-Rauf, PW Pincus, MR Monaco, R Abarzua, P Fine, RL
Citation: Al. Kim et al., Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells, J BIOL CHEM, 274(49), 1999, pp. 34924-34931
Risultati: 1-17 |